102 related articles for article (PubMed ID: 3219138)
21. Absorption, distribution and excretion of 14C-benidipine hydrochloride after repeated administration to rats.
Kobayashi H; Ohishi T; Nishiie H; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1747-9. PubMed ID: 3219153
[TBL] [Abstract][Full Text] [Related]
22. Benidipine hydrochloride (KW-3049): a new dihydropyridine calcium antagonist.
Arzneimittelforschung; 1988 Nov; 38(11A):1661-763. PubMed ID: 3219136
[No Abstract] [Full Text] [Related]
23. Nitrendipine: identification and synthesis of main metabolites.
Meyer H; Scherling D; Karl W
Arzneimittelforschung; 1983; 33(11):1528-34. PubMed ID: 6686447
[TBL] [Abstract][Full Text] [Related]
24. Effects of the new calcium antagonist benidipine hydrochloride on cardiohemodynamics in anesthetized dogs.
Karasawa A; Kubo K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1713-6. PubMed ID: 3219146
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
26. Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate.
Tamazawa K; Arima H; Kojima T; Isomura Y; Okada M; Fujita S; Furuya T; Takenaka T; Inagaki O; Terai M
J Med Chem; 1986 Dec; 29(12):2504-11. PubMed ID: 3023614
[TBL] [Abstract][Full Text] [Related]
27. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
Rovnyak GC; Atwal KS; Hedberg A; Kimball SD; Moreland S; Gougoutas JZ; O'Reilly BC; Schwartz J; Malley MF
J Med Chem; 1992 Aug; 35(17):3254-63. PubMed ID: 1387168
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):337-41. PubMed ID: 3255335
[TBL] [Abstract][Full Text] [Related]
30. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
[TBL] [Abstract][Full Text] [Related]
31. [Strategies for the synthesis of nifedipine analog esters of l-ascorbic acid].
Görlitzer K; Baltrusch HJ
Pharmazie; 2001 Mar; 56(3):208-13. PubMed ID: 11265584
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
Shafiee A; Rastkary N; Jorjani M; Shafaghi B
Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and calcium channel antagonist activity of alkyl t-butyl esters of nifedipine analogues containing pyridinyl substituents.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1987 Dec; 2(2):79-89. PubMed ID: 2855571
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of impurities of barnidipine hydrochloride, an antihypertensive drug substance.
Cheng ZG; Dai XY; Li LW; Wan Q; Ma X; Xiang GY
Molecules; 2014 Jan; 19(1):1344-52. PubMed ID: 24451253
[TBL] [Abstract][Full Text] [Related]
37. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.
Atwal KS; Swanson BN; Unger SE; Floyd DM; Moreland S; Hedberg A; O'Reilly BC
J Med Chem; 1991 Feb; 34(2):806-11. PubMed ID: 1995904
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
39. Preparation and properties of ryodipine, an effective antihypertensive agent.
Kastron VV; Dubur GJ; Shatz VD; Yagupolsky LM
Arzneimittelforschung; 1985; 35(4):668-72. PubMed ID: 4015732
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.
Ohno S; Komatsu O; Mizukoshi K; Ichihara K; Nakamura Y; Morishima T; Sumita K
Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1589-606. PubMed ID: 3719860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
